Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition

J Exp Med. 1992 July 1; 176(1): 119–128.

PMCID: PMC2119300

This article has been cited by other articles in PMC.

Abstract

The routes used by antigen-presenting cells (APC) to convert the transmembrane fusion glycoprotein (F) of measles virus (MV) to HLA class I and class II presentable peptides have been examined, using cloned cytotoxic T lymphocytes in functional assays. Presentation by Epstein-Barr virus-transformed B lymphoblastoid cell lines was achieved using live virus, ultraviolet light-inactivated virus, and purified MV- F delivered either as such or incorporated in immunostimulating complexes (MV-F-ISCOM). Only live virus and MV-F-ISCOM allow presentation by class I molecules, while all antigen preparations permit class II-restricted presentation. We observe presentation of MV- F from live virus and as MV-F-ISCOM by class II molecules in a fashion that is not perturbed by chloroquine. Our studies visualize novel presentation pathways of type I transmembrane proteins.

Full Text

The Full Text of this article is available as a PDF (1.1M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Long, EO. Intracellular traffic and antigen processing. Immunol Today. 1989 Jul;10(7):232–234. [PubMed]
Townsend, A; Bodmer, H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol. 1989;7:601–624. [PubMed]
Yewdell, JW; Bennink, JR. The binary logic of antigen processing and presentation to T cells. Cell. 1990 Jul 27;62(2):203–206. [PubMed]
Braciale, TJ; Braciale, VL. Antigen presentation: structural themes and functional variations. Immunol Today. 1991 Apr;12(4):124–129. [PubMed]
Sadegh-Nasseri, S; Germain, RN. How MHC class II molecules work: peptide-dependent completion of protein folding. Immunol Today. 1992 Feb;13(2):43–46. [PubMed]
Lanzavecchia, A. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol. 1990;8:773–793. [PubMed]
Harding, CV; Collins, DS; Slot, JW; Geuze, HJ; Unanue, ER. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell. 1991 Jan 25;64(2):393–401. [PubMed]
Ziegler, HK; Unanue, ER. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A. 1982 Jan;79(1):175–178. [PubMed]
Streicher, HZ; Berkower, IJ; Busch, M; Gurd, FR; Berzofsky, JA. Antigen conformation determines processing requirements for T-cell activation. Proc Natl Acad Sci U S A. 1984 Nov;81(21):6831–6835. [PubMed]
Buus, S; Werdelin, O. A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells. J Immunol. 1986 Jan;136(2):452–458. [PubMed]
Babbitt, BP; Matsueda, G; Haber, E; Unanue, ER; Allen, PM. Antigenic competition at the level of peptide-Ia binding. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4509–4513. [PubMed]
Buus, S; Sette, A; Colon, SM; Jenis, DM; Grey, HM. Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell. 1986 Dec 26;47(6):1071–1077. [PubMed]
Neefjes, JJ; Stollorz, V; Peters, PJ; Geuze, HJ; Ploegh, HL. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell. 1990 Apr 6;61(1):171–183. [PubMed]
Germain, RN; Hendrix, LR. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature. 1991 Sep 12;353(6340):134–139. [PubMed]
Sadegh-Nasseri, S; Germain, RN. A role for peptide in determining MHC class II structure. Nature. 1991 Sep 12;353(6340):167–170. [PubMed]
Wettstein, DA; Boniface, JJ; Reay, PA; Schild, H; Davis, MM. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J Exp Med. 1991 Jul 1;174(1):219–228. [PubMed]
Peters, PJ; Neefjes, JJ; Oorschot, V; Ploegh, HL; Geuze, HJ. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature. 1991 Feb 21;349(6311):669–676. [PubMed]
Townsend, AR; Gotch, FM; Davey, J. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell. 1985 Sep;42(2):457–467. [PubMed]
Townsend, AR; Rothbard, J; Gotch, FM; Bahadur, G; Wraith, D; McMichael, AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 1986 Mar 28;44(6):959–968. [PubMed]
Bastin, J; Rothbard, J; Davey, J; Jones, I; Townsend, A. Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. J Exp Med. 1987 Jun 1;165(6):1508–1523. [PubMed]
Maryanski, JL; Pala, P; Corradin, G; Jordan, BR; Cerottini, JC. H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature. 1986 Dec 11;324(6097):578–579. [PubMed]
Townsend, AR; Bastin, J; Gould, K; Brownlee, GG. Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence. Nature. 1986 Dec 11;324(6097):575–577. [PubMed]
Braciale, TJ; Braciale, VL; Winkler, M; Stroynowski, I; Hood, L; Sambrook, J; Gething, MJ. On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes. J Exp Med. 1987 Sep 1;166(3):678–692. [PubMed]
Yewdell, JW; Bennink, JR; Hosaka, Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science. 1988 Feb 5;239(4840):637–640. [PubMed]
Moore, MW; Carbone, FR; Bevan, MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 1988 Sep 9;54(6):777–785. [PubMed]
Carbone, FR; Bevan, MJ. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med. 1990 Feb 1;171(2):377–387. [PubMed]
Sweetser, MT; Braciale, VL; Braciale, TJ. Class I MHC-restricted recognition of cells expressing a gene encoding a 41 amino acid product of the influenza hemagglutinin. J Immunol. 1988 Nov 15;141(10):3324–3328. [PubMed]
Townsend, A; Bastin, J; Gould, K; Brownlee, G; Andrew, M; Coupar, B; Boyle, D; Chan, S; Smith, G. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med. 1988 Oct 1;168(4):1211–1224. [PubMed]
Calin-Laurens, V; Forquet, F; Mottez, E; Kanellopoulos, J; Godeau, F; Kourilsky, P; Gerlier, D; Rabourdin-Combe, C. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules. Eur J Immunol. 1991 Mar;21(3):761–769. [PubMed]
Yewdell, JW; Bennink, JR. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science. 1989 Jun 2;244(4908):1072–1075. [PubMed]
Sweetser, MT; Morrison, LA; Braciale, VL; Braciale, TJ. Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells. Nature. 1989 Nov 9;342(6246):180–182. [PubMed]
Nuchtern, JG; Bonifacino, JS; Biddison, WE; Klausner, RD. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature. 1989 May 18;339(6221):223–226. [PubMed]
Townsend, A; Ohlén, C; Bastin, J; Ljunggren, HG; Foster, L; Kärre, K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature. 1989 Aug 10;340(6233):443–448. [PubMed]
Cerundolo, V; Alexander, J; Anderson, K; Lamb, C; Cresswell, P; McMichael, A; Gotch, F; Townsend, A. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature. 1990 May 31;345(6274):449–452. [PubMed]
Hosken, NA; Bevan, MJ. Defective presentation of endogenous antigen by a cell line expressing class I molecules. Science. 1990 Apr 20;248(4953):367–370. [PubMed]
Ljunggren, HG; Stam, NJ; Ohlén, C; Neefjes, JJ; Höglund, P; Heemels, MT; Bastin, J; Schumacher, TN; Townsend, A; Kärre, K, et al. Empty MHC class I molecules come out in the cold. Nature. 1990 Aug 2;346(6283):476–480. [PubMed]
Townsend, A; Elliott, T; Cerundolo, V; Foster, L; Barber, B; Tse, A. Assembly of MHC class I molecules analyzed in vitro. Cell. 1990 Jul 27;62(2):285–295. [PubMed]
Elliott, T; Cerundolo, V; Elvin, J; Townsend, A. Peptide-induced conformational change of the class I heavy chain. Nature. 1991 May 30;351(6325):402–406. [PubMed]
Schumacher, TN; De Bruijn, ML; Vernie, LN; Kast, WM; Melief, CJ; Neefjes, JJ; Ploegh, HL. Peptide selection by MHC class I molecules. Nature. 1991 Apr 25;350(6320):703–706. [PubMed]
Kvist, S; Hamann, U. A nucleoprotein peptide of influenza A virus stimulates assembly of HLA-B27 class I heavy chains and beta 2-microglobulin translated in vitro. Nature. 1990 Nov 29;348(6300):446–448. [PubMed]
Silver, ML; Parker, KC; Wiley, DC. Reconstitution by MHC-restricted peptides of HLA-A2 heavy chain with beta 2-microglobulin, in vitro. Nature. 1991 Apr 18;350(6319):619–622. [PubMed]
Staerz, UD; Karasuyama, H; Garner, AM. Cytotoxic T lymphocytes against a soluble protein. Nature. 329(6138):449–451. [PubMed]
Jin, Y; Shih, WK; Berkower, I. Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J Exp Med. 1988 Jul 1;168(1):293–306. [PubMed]
Takahashi, H; Takeshita, T; Morein, B; Putney, S; Germain, RN; Berzofsky, JA. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature. 1990 Apr 26;344(6269):873–875. [PubMed]
Mowat, AM; Donachie, AM; Reid, G; Jarrett, O. Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology. 1991 Mar;72(3):317–322. [PubMed]
Randall, RE; Young, DF. Solid matrix-antibody-antigen complexes induce antigen-specific CD8+ cells that clear a persistent paramyxovirus infection. J Virol. 1991 Feb;65(2):719–726. [PubMed]
Heeg, K; Kuon, W; Wagner, H. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide. Eur J Immunol. 1991 Jun;21(6):1523–1527. [PubMed]
Schrader, JW; Edelman, GM. Joint recognition by cytotoxic T cells of inactivated Sendai virus and products of the major histocompatibility complex. J Exp Med. 1977 Mar 1;145(3):523–539. [PubMed]
Koszinowski, U; Gething, MJ; Waterfield, M. T-cell cytotoxicity in the absence of viral protein synthesis in target cells. Nature. 1977 May 12;267(5607):160–163. [PubMed]
Jacobson, S; Sekaly, RP; Jacobson, CL; McFarland, HF; Long, EO. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol. 1989 Apr;63(4):1756–1762. [PubMed]
Jaraquemada, D; Marti, M; Long, EO. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J Exp Med. 1990 Sep 1;172(3):947–954. [PubMed]
Chen, BP; Madrigal, A; Parham, P. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J Exp Med. 1990 Sep 1;172(3):779–788. [PubMed]
Weiss, S; Bogen, B. MHC class II-restricted presentation of intracellular antigen. Cell. 1991 Feb 22;64(4):767–776. [PubMed]
Brooks, A; Hartley, S; Kjer-Nielsen, L; Perera, J; Goodnow, CC; Basten, A; McCluskey, J. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3290–3294. [PubMed]
Hackett, CJ; Yewdell, JW; Bennink, JR; Wysocka, M. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation. J Immunol. 1991 May 1;146(9):2944–2951. [PubMed]
Graves, MC; Silver, SM; Choppin, PW. Measles virus polypeptides synthesis in infected cells. Virology. 1978 May 1;86(1):254–263. [PubMed]
Sato, TA; Kohama, T; Sugiura, A. Intracellular processing of measles virus fusion protein. Arch Virol. 1988;98(1-2):39–50. [PubMed]
de Vries, P; van Binnendijk, RS; van der Marel, P; van Wezel, AL; Voorma, HO; Sundquist, B; Uytdehaag, FG; Osterhaus, AD. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J Gen Virol. 1988 Mar;69 (:549–559. [PubMed]
Morein, B; Sundquist, B; Höglund, S; Dalsgaard, K; Osterhaus, A. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature. 308(5958):457–460. [PubMed]
Fossum, C; Bergström, M; Lövgren, K; Watson, DL; Morein, B. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix. Cell Immunol. 1990 Sep;129(2):414–425. [PubMed]
van Binnendijk, RS; Poelen, MC; de Vries, P; Voorma, HO; Osterhaus, AD; Uytdehaag, FG. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones. J Immunol. 1989 Apr 15;142(8):2847–2854. [PubMed]
van Binnendijk, RS; Poelen, MC; Kuijpers, KC; Osterhaus, AD; Uytdehaag, FG. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL. J Immunol. 1990 Mar 15;144(6):2394–2399. [PubMed]
Huet, S; Nixon, DF; Rothbard, JB; Townsend, A; Ellis, SA; McMichael, AJ. Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27. Int Immunol. 1990;2(4):311–316. [PubMed]
Trowsdale, J; Hanson, I; Mockridge, I; Beck, S; Townsend, A; Kelly, A. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature. 348(6303):741–744. [PubMed]
Deverson, EV; Gow, IR; Coadwell, WJ; Monaco, JJ; Butcher, GW; Howard, JC. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature. 348(6303):738–741. [PubMed]
Spies, T; Bresnahan, M; Bahram, S; Arnold, D; Blanck, G; Mellins, E; Pious, D; DeMars, R. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature. 1990 Dec 20;348(6303):744–747. [PubMed]
Monaco, JJ; Cho, S; Attaya, M. Transport protein genes in the murine MHC: possible implications for antigen processing. Science. 1990 Dec 21;250(4988):1723–1726. [PubMed]
Anderson, K; Cresswell, P; Gammon, M; Hermes, J; Williamson, A; Zweerink, H. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J Exp Med. 1991 Aug 1;174(2):489–492. [PubMed]
Spies, T; DeMars, R. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature. 1991 May 23;351(6324):323–324. [PubMed]
Dunn, WA., Jr Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J Cell Biol. 1990 Jun;110(6):1923–1933. [PubMed]